Dr. Kingman Strohl, MD

NPI: 1053331124
Total Payments
$19,097
2024 Payments
$174.57
Companies
12
Transactions
64
Medicare Patients
286
Medicare Billing
$18,433

Payment Breakdown by Category

Consulting$13,270 (69.5%)
Travel$3,009 (15.8%)
Food & Beverage$2,663 (13.9%)
Education$154.98 (0.8%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $13,270 14 69.5%
Travel and Lodging $3,009 6 15.8%
Food and Beverage $2,663 42 13.9%
Education $154.98 2 0.8%

Top Paying Companies

Company Total Records Latest Year
JAZZ PHARMACEUTICALS INC. $7,794 19 $0 (2022)
Eisai Inc. $4,250 1 $0 (2021)
Merck Sharp & Dohme LLC $3,614 13 $0 (2023)
Inspire Medical Systems, Inc. $2,923 9 $0 (2024)
Harmony Biosciences LLC $298.61 9 $0 (2023)
AstraZeneca Pharmaceuticals LP $117.53 7 $0 (2023)
Avadel CNS Pharmaceuticals, LLC $21.34 1 $0 (2024)
Electromed, Inc. $17.28 1 $0 (2023)
Teva Pharmaceuticals USA, Inc. $17.28 1 $0 (2023)
Mylan Specialty L.P. $16.58 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $174.57 2 Inspire Medical Systems, Inc. ($153.23)
2023 $1,005 21 Merck Sharp & Dohme LLC ($413.81)
2022 $904.42 7 Merck Sharp & Dohme LLC ($650.00)
2021 $4,771 3 Eisai Inc. ($4,250)
2020 $1,225 5 Merck Sharp & Dohme Corporation ($1,113)
2019 $934.63 3 Inspire Medical Systems, Inc. ($594.63)
2018 $2,122 7 Inspire Medical Systems, Inc. ($1,722)
2017 $7,959 16 Jazz Pharmaceuticals Inc. ($7,415)

All Payment Transactions

64 individual payment records from CMS Open Payments — Page 3 of 3

Date Company Product Nature Form Amount Type
12/05/2017 Jazz Pharmaceuticals Inc. Travel and Lodging Cash or cash equivalent $32.84 General
11/18/2017 Jazz Pharmaceuticals Inc. Travel and Lodging Cash or cash equivalent $1,064.92 General
11/18/2017 Jazz Pharmaceuticals Inc. Travel and Lodging Cash or cash equivalent $258.77 General
11/18/2017 Jazz Pharmaceuticals Inc. Food and Beverage Cash or cash equivalent $142.87 General
11/18/2017 Jazz Pharmaceuticals Inc. Food and Beverage Cash or cash equivalent $105.29 General
11/18/2017 Jazz Pharmaceuticals Inc. Food and Beverage Cash or cash equivalent $83.89 General
11/18/2017 Jazz Pharmaceuticals Inc. Food and Beverage Cash or cash equivalent $56.77 General
07/28/2017 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $340.00 General
07/13/2017 Jazz Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $1,200.00 General
06/29/2017 Jazz Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $400.00 General
06/07/2017 Jazz Pharmaceuticals Inc. Food and Beverage In-kind items and services $33.49 General
06/06/2017 Jazz Pharmaceuticals Inc. Food and Beverage In-kind items and services $90.26 General
05/21/2017 Inspire Medical Systems, Inc. Inspire Upper Airway Stimulation System (Device) Food and Beverage Cash or cash equivalent $203.73 General
Category: Neurology
04/30/2017 Jazz Pharmaceuticals Inc. Food and Beverage In-kind items and services $56.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 77 84 $17,144 $5,309
2022 3 69 87 $13,476 $4,876
2021 3 55 58 $8,294 $3,596
2020 4 85 98 $13,924 $4,652
Total Patients
286
Total Services
327
Medicare Billing
$18,433
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 36 43 $6,794 $3,030 44.6%
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older) Facility 2023 11 11 $5,478 $1,052 19.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 14 14 $1,400 $620.64 44.3%
95806 Sleep study including heart rate, breathing, airflow, and effort Office 2023 16 16 $3,472 $606.54 17.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 28 42 $6,636 $2,751 41.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 21 25 $2,500 $1,318 52.7%
95806 Sleep study including heart rate, breathing, airflow, and effort Office 2022 20 20 $4,340 $806.51 18.6%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 24 26 $4,108 $1,776 43.2%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2021 16 17 $2,686 $1,098 40.9%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 15 15 $1,500 $722.57 48.2%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2020 32 39 $5,402 $2,342 43.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 20 21 $3,318 $1,066 32.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 21 26 $2,600 $828.02 31.8%
95806 Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort Office 2020 12 12 $2,604 $415.32 15.9%

About Dr. Kingman Strohl, MD

Dr. Kingman Strohl, MD is a Critical Care Medicine healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053331124.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kingman Strohl, MD has received a total of $19,097 in payments from pharmaceutical and medical device companies, with $174.57 received in 2024. These payments were reported across 64 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($13,270).

As a Medicare-enrolled provider, Strohl has provided services to 286 Medicare beneficiaries, totaling 327 services with total Medicare billing of $18,433. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Critical Care Medicine
  • Location Cleveland, OH
  • Active Since 07/20/2006
  • Last Updated 01/13/2021
  • Taxonomy Code 207RC0200X
  • Entity Type Individual
  • NPI Number 1053331124

Products in Payments

  • Dayvigo (Drug) $4,250
  • Inspire Upper Airway Stimulation System (Device) $2,520
  • INSPIRE (Device) $403.32
  • WAKIX (Drug) $203.62
  • XYWAV (Drug) $145.44
  • SUNOSI (Drug) $112.07
  • Wakix (Drug) $94.99
  • BREZTRI (Drug) $42.96
  • ZERBAXA (Drug) $30.65
  • FASENRA (Drug) $23.75
  • LUMRYZ (Drug) $21.34
  • SYMBICORT (Drug) $19.55
  • AirDuo Digihaler (Drug) $17.28
  • SMARTVEST (Device) $17.28
  • YUPELRI (Drug) $16.58
  • TEZSPIRE (Biological) $16.27
  • AIRSUPRA (Drug) $15.00
  • DIFICID (Drug) $13.81
  • XIFAXAN (Drug) $13.72
  • LUNA (Device) $12.82

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Critical Care Medicine Doctors in Cleveland